安耐糖持续血糖监测系列

Search documents
鱼跃医疗收盘上涨2.90%,滚动市盈率19.99倍,总市值377.53亿元
Sou Hu Cai Jing· 2025-08-25 08:53
Company Overview - Yuyue Medical's closing price on August 25 was 37.66 yuan, with an increase of 2.90%, resulting in a rolling PE ratio of 19.99, the lowest in 60 days, and a total market capitalization of 37.753 billion yuan [1] - The company operates in the home medical device and clinical medical product sectors, with key products including ventilators, continuous glucose monitoring systems branded as "Annai Sugar," and electronic blood pressure monitors [1] - Yuyue Medical's Huatuo brand was recognized as a "Chinese Time-honored Brand" by the Ministry of Commerce in 2011 [1] Financial Performance - For the first half of 2025, Yuyue Medical reported revenue of 4.659 billion yuan, a year-on-year increase of 8.16%, and a net profit of 1.203 billion yuan, up 7.37%, with a gross profit margin of 50.37% [1] Shareholder Information - As of August 8, 2025, Yuyue Medical had 50,000 shareholders, with no change from the previous count, an average holding value of 352,800 yuan per shareholder, and an average shareholding of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 55.91, with a median of 40.36, placing Yuyue Medical at 43rd in the industry ranking [1][2] - Other companies in the industry include Jiuan Medical with a PE of 11.75, Yingke Medical at 16.04, and Xinhua Medical at 16.21, indicating a significant disparity in valuation compared to Yuyue Medical [2]